Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM

Current Hematologic Malignancy Reports

Volumn 11, Issue 6, 2016, Pages 456-461

  Pemmaraju, Naveen ^a   Utengen, Audun ^b   Gupta, Vikas ^c   Kiladjian, Jean Jacques ^d   Mesa, Ruben ^e   Thompson, Michael A ^f  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Symplur LLC   (United States)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e MAYO CLINIC   (United States)

^f Aurora Health Care   (United States)

Author keywords

Disease specific hashtag; Myelofibrosis; Myeloproliferative neoplasm; Polycythemia vera; Social media; Twitter

Indexed keywords

CANCER RESEARCH; HEALTH CARE; INTERPERSONAL COMMUNICATION; MEDICAL INFORMATION; MYELOPROLIFERATIVE NEOPLASM; NONHUMAN; ONLINE SYSTEM; REVIEW; SOCIAL MEDIA; HEMATOLOGIC NEOPLASMS; HUMAN; INTERNET; MEDICAL INFORMATION SYSTEM; MYELOPROLIFERATIVE DISORDERS; ORGANIZATION; PATHOLOGY; PSYCHOLOGY;

CONGRESSES AS TOPIC; HEALTH INFORMATION EXCHANGE; HEMATOLOGIC NEOPLASMS; HUMANS; INTERNET; MYELOPROLIFERATIVE DISORDERS; SOCIAL MEDIA;

EID: 84982902934     PISSN: 15588211     EISSN: 1558822X     Source Type: Journal    
DOI: 10.1007/s11899-016-0341-2     Document Type: Review

References (18)

1. Abernethy AP, Grubbs SS. Managing cumulative expectations in oncology: challenges and potential solutions. Am Soc Clin Oncol Educ Book. 2014;e140-144. doi:10.14694/EdBook_AM.2014.34.e140
2. Savage N. Scientists in the twitterverse. Cell. 2015;162(2):233–4.
3. Thompson MA. Using social media to learn and communicate: it is not about the tweet. Am Soc Clin Oncol Educ Book. 2015;206–211.
4. Borgmann H, Loeb S, Salem J, et al. Activity, content, contributors, and influencers of the twitter discussion on urologic oncology. Urol Oncol. 2016.
5. Attai DJ, Cowher MS, Al-Hamadani M, Schoger JM, Staley AC, Landercasper J. Twitter social media is an effective tool for breast cancer patient education and support: patient-reported outcomes by survey. J sMed Internet Res. 2015;17(7):e188.
6. Thompson MA, Majhail NS, Wood WA, Perales MA, Chaboissier M. Social media and the practicing hematologist: twitter 101 for the busy healthcare provider. Curr Hematol Malig Rep. 2015;10(4):405–12.
7. Salem J, Borgmann H, Murphy DG. Integrating social media into urologic health care: what can we learn from other disciplines? Curr Urol Rep. 2016;17(2):13.
8. Park S, Oh HK, Park G, et al. The source and credibility of colorectal cancer information on twitter. Medicine. 2016;95(7):e2775.
9. Pemmaraju N, Moliterno AR. From Philadelphia-negative to JAK2-positive: effect of genetic discovery on risk stratification and management. Am Soc Clin Oncol Educ Book. 2015;35:139–45.
10. Verstovsek S, Komrokji RS. Novel and emerging therapies for the treatment of polycythemia vera. Expert Rev Hematol. 2015;8(1):101–13.
11. Geyer HL, Mesa RA. Emerging drugs for the treatment of myelofibrosis. Expert Opin Emerg Drugs. 2015;20(4):663–78.
12. Stein BL, Gotlib J, Arcasoy M, et al. Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms. J Natl Compr Canc Netw. 2015;13(4):424–34.
13. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management. Am J Hematol. 2015;90(2):162–73.
14. Pemmaraju N, Gupta V, Mesa R, Thompson MA. Social media and myeloproliferative neoplasms (mpn)-focus on twitter and the development of a disease-specific community: #MPNSM. Curr Hematol Malig Rep. 2015.
15. Katz MS, Utengen A, Anderson PF, Thompson MA, Fisch M, Johnston C. Disease-specific hashtags for online communication about cancer care. J Clin Oncol. 2015;33:6520.
16. Sedrak MS, Cohen RB, Merchant RM, Schapira MM. Cancer Communication in the Social Media Age. JAMA Oncol. 2016;2(6):822-3.
17. Perales MA, Drake EK, Pemmaraju N, Wood WA. Social media and the adolescent and young adult (aya) patient with cancer. Curr Hematol Malig Rep. 2016.
18. Thompson MA. Social media in clinical trials. Am Soc Clin Oncol Educ Book. 2014; e101-105. doi:10.14694/EdBook_AM.2014.34.e101